Understanding the Oxygen-Sensing Pathway and Its Therapeutic Implications in Diseases

Am J Pathol. 2020 Aug;190(8):1584-1595. doi: 10.1016/j.ajpath.2020.04.003. Epub 2020 Apr 24.

Abstract

Maintaining oxygen homeostasis is a most basic cellular process for adapting physiological oxygen variations, and its abnormality typically leads to various disorders in the human body. The key molecules of the oxygen-sensing system include the transcriptional regulator hypoxia-inducible factor (HIF), which controls a wide range of oxygen responsive target genes (eg, EPO and VEGF), certain members of the oxygen/2-oxoglutarate-dependent dioxygenase family, including the HIF proline hydroxylase (PHD, alias EGLN), and an E3 ubiquitin ligase component for HIF destruction called von Hippel-Lindau. In this review, we summarize the physiological role and highlight the pathologic function for each protein of the oxygen-sensing system. A better understanding of their molecular mechanisms of action will help uncover novel therapeutic targets and develop more effective treatment approaches for related human diseases, including cancer.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Review

MeSH terms

  • Humans
  • Hypoxia / metabolism
  • Hypoxia-Inducible Factor 1 / metabolism*
  • Neoplasms / metabolism
  • Oxygen / metabolism*
  • Procollagen-Proline Dioxygenase / metabolism*
  • Von Hippel-Lindau Tumor Suppressor Protein / metabolism*

Substances

  • Hypoxia-Inducible Factor 1
  • Procollagen-Proline Dioxygenase
  • Von Hippel-Lindau Tumor Suppressor Protein
  • Oxygen